UCB
Showing 1 - 25 of 882
Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
Not yet recruiting
- Huntington Disease
- [11C]UCB-J
- [18F]SynVest-1
-
Leuven, BelgiumUZ Leuven
Nov 2, 2022
UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic
Recruiting
- UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
- Basic chemotherapy + UCB transplantation
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Oct 9, 2022
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A
Recruiting
- Cocaine Use Disorder
- Healthy Controls
- 11C-UCB-J
-
New Haven, ConnecticutConnecticut Mental Health Center
Aug 10, 2022
Opiate Dependence, Cocaine Dependence Trial in New Haven (11UCB-J PET Scan)
Recruiting
- Opiate Dependence
- Cocaine Dependence
- 11UCB-J PET Scan
-
New Haven, ConnecticutCT Mental Health Center
May 20, 2022
Osteoarthritis, Knee Trial in Ljubljana (Knee aspiration + UCB-MSCs, Knee aspiration)
Recruiting
- Osteoarthritis, Knee
- Knee aspiration + UCB-MSCs
- Knee aspiration
-
Ljubljana, SloveniaUniversity medical centre Ljubljana
Oct 5, 2023
Lymphatic Diseases, Hematopoietic Malignancy Trial in Minneapolis (Umbilical Cord Blood (UCB))
Recruiting
- Lymphatic Diseases
- Hematopoietic Malignancy
- Umbilical Cord Blood (UCB)
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 25, 2023
Atopic Dermatitis Trial in Glendale (UCB1381, Placebo)
Recruiting
- Atopic Dermatitis
- UCB1381
- Placebo
-
Glendale, CaliforniaUp0110 101
Jan 20, 2023
Healthy Study Participants, Chronic Spontaneous Urticaria Trial in Sofia (UCB8600, Placebo)
Terminated
- Healthy Study Participants
- Chronic Spontaneous Urticaria
- UCB8600
- Placebo
-
Sofia, BulgariaUp0086 001
Jul 15, 2022
Alzheimer Trial in Lille, Paris, Rouen ([11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948)
Not yet recruiting
- Alzheimer Disease
- [11C]-UCB-J
- +3 more
-
Lille, France
- +2 more
Jun 12, 2023
Cannabis Use Trial in New Haven ([11C]UCB-J PET)
Recruiting
- Cannabis Use
- [11C]UCB-J PET
-
New Haven, ConnecticutConnecticut Mental Health Center
Aug 17, 2022
Adrenoleukodystrophy, Batten Disease, Mucopolysaccharidosis II Trial in Durham (DUOC-01)
Recruiting
- Adrenoleukodystrophy
- +11 more
- DUOC-01
-
Durham, North CarolinaDuke University Medical Center
Oct 24, 2022
British Axial Spondyloarthritis Inception Cohort
Not yet recruiting
- Axial Spondyloarthritis
- No intervenetion
-
Leeds, United KingdomChapel Allerton Hospital
Jan 6, 2023
Generalized Myasthenia Gravis Trial (rozanolixizumab)
Not yet recruiting
- Generalized Myasthenia Gravis
- (no location specified)
Nov 28, 2023
Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study
Recruiting
- Parkinson Disease
- No intervention
-
Kiel, GermanyDepartment for Neurology, University of Kiel
Dec 31, 2022
Chronic Fatigue Syndrome Trial in Ghent (Sodium oxybate, Placebo)
Withdrawn
- Chronic Fatigue Syndrome
- Sodium oxybate
- Placebo
-
Ghent, BelgiumGhent University Hospital
Dec 14, 2022
Cerebral Palsy Trial in Samara (CP CB-MNC injection, Standard therapy)
Recruiting
- Cerebral Palsy
- CP CB-MNC injection
- Standard therapy
-
Samara, Russian FederationMedical Centre Dinasty
Jan 17, 2023
Huntington Disease Trial in Leuven (11C-UCB-J PET-CT, 18F-FDG PET-MR)
Active, not recruiting
- Huntington Disease
- 11C-UCB-J PET-CT
- 18F-FDG PET-MR
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
May 18, 2022
Parkinson Disease Trial in Leuven (11C-UCB-J PET-CT, 18F-PE2I PET-MR)
Completed
- Parkinson Disease
- 11C-UCB-J PET-CT
- 18F-PE2I PET-MR
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
May 18, 2022